HCC Outcomes mitigation and disease Prevention through Clinical Partnerships (HOPE)

Lead Researcher: Professor Christopher Liddle

Institution: University of Sydney (NSW)

Funding: $523,538

Funding Duration: 2014 - 2016

‍

The Research

Seeks to develop and implement a chronic viral hepatitis B mitigation program than can prevent  the development of liver cancer.